MannKind Corporation (NASDAQ:MNKD) Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit September 22, 2021 2:55 PM ET Company Participants Michael Castagna - CEO Conference Call Participants Michael Castagna Good afternoon, and thank you for joining us on our Oppenheimer Healthcare Life Sciences & Med Tech Summit today. My name is Mike Castagna, I'm the CEO of MannKind and I'm here to try give you an update, really quickly for new investors on the company and for existing investors any key updates w ...

MannKind Corporation (NASDAQ:MNKD) H.C. Wainwright 23rd Annual Global Investment Conference September 13, 2021 7:00 AM ET Company Participants Michael Castagna - Chief Executive Officer Conference Call Participants Oren Livnat - H.C. Wainwright Oren Livnat Hello and welcome to the H.C. Wainwright 23rd Annual Global Investment Conference. My name is Oren Livnat, I'm a specialty pharmaceuticals analyst here at H.C. Wainwright and it's my pleasure to welcome for a brief chat today, Michael Castagna, Chief Exec ...

MannKind Corporation (NASDAQ:MNKD) Q2 2021 Earnings Conference Call August 11, 2021 5:00 PM ET Company Participants Michael Castagna - Chief Executive Officer Steven Binder - Chief Financial Officer Stuart Tross - Head, Human Resources Conference Call Participants Brandon Folkes - Cantor Fitzgerald Daniel Busby - RBC Capital Markets Steve Lichtman - Oppenheimer Thomas Smith - SVB Leerink Bert Hazlett - BTIG Operator Good afternoon and welcome to the MannKind Corporation Second Quarter 2021 Earnings Call. As ...

MannKind Corporation (NASDAQ:MNKD) Lytham Partners Summer 2021 Investor Conference June 14, 2021 11:45 AM ET Company Participants Michael Castagna - CEO Conference Call Participants Robert Blum - Lytham Partners Robert Blum All right. Hello, everyone and thank you all for joining us during the Lytham Partners Summer 2021 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. Our next presentation comes from MannKind, ticker symbol of MNKD on the NASDAQ. Presenting from the Company ...

MannKind Corporation (NASDAQ:MNKD) 2021 RBC Capital Markets Global Healthcare Conference Call May 18, 2021 4:15 PM ET Company Participants Michael Castagna - Chief Executive Officer Conference Call Participants Daniel Busby - Pharmaceuticals Equity Research Analyst, RBC capital markets Daniel Busby I'm Dan Busby, the pharmaceuticals analyst at RBC Capital Markets. Our next company presenting today is MannKind Corporation, which we recently initiated coverage on. And I'm pleased to be joined by Michael Casta ...